| Autor: |
Cabrero M; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yu Y; Albert Einstein College of Medicine, Bronx, NY, USA., Verma A; Albert Einstein College of Medicine, Bronx, NY, USA., Yang H; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Colla S; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jia Y; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zheng H; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bohannan Z; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ganan-Gomez I; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal A; Departments of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Takahashi K; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chin L; Departments of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pellagatti A; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Bowman T; Albert Einstein College of Medicine, Bronx, NY, USA., Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Garcia-Manero G; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wei Y; Departments of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywei@mdanderson.org. |
Plný text